{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:46:44Z","timestamp":1785826004475,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.7759\/cureus.113913","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:07:01Z","timestamp":1785823621000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset Antiphospholipid Syndrome Presenting With Recurrent Multifocal Ischemic Strokes: Diagnostic and Management Challenges"],"prefix":"10.7759","author":[{"given":"Mariam","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Boadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza G","year":"2010","unstructured":"Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010, 376:1498-1509. 10.1016\/S0140-6736(10)60709-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1527554","article-title":"Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome","volume":"16","author":"Yang L","year":"2025","unstructured":"Yang L, Guo R, Liu H, et al.. Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome. Front Immunol. 2025, 16:1527554. 10.3389\/fimmu.2025.1527554","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14010024","article-title":"Stroke and risk factors in antiphospholipid syndrome","volume":"14","author":"Fan Y","year":"2024","unstructured":"Fan Y, Xu Y, Zhang S, Song X, Liu Z, Tu W, Li C. Stroke and risk factors in antiphospholipid syndrome. J Pers Med. 2024, 14:24. 10.3390\/jpm14010024","journal-title":"J Pers Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4431907","article-title":"Was antiphospholipid syndrome a risk factor of stroke? A systemic review and meta-analysis of cohort studies","volume":"2021","author":"Zhao K","year":"2021","unstructured":"Zhao K, Zhou P, Xu L, et al.. Was antiphospholipid syndrome a risk factor of stroke? A systemic review and meta-analysis of cohort studies. Dis Markers. 2021, 2021:4431907. 10.1155\/2021\/4431907","journal-title":"Dis Markers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key437","article-title":"Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study","volume":"58","author":"Grimaud F","year":"2019","unstructured":"Grimaud F, Yelnik C, Pineton de Chambrun M, et al.. Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study. Rheumatology (Oxford). 2019, 58:1006-1010. 10.1093\/rheumatology\/key437","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2192403","article-title":"Current perspectives on the clinical management of cryptogenic stroke","volume":"23","author":"Yang D","year":"2023","unstructured":"Yang D, Elkind MS. Current perspectives on the clinical management of cryptogenic stroke. Expert Rev Neurother. 2023, 23:213-226. 10.1080\/14737175.2023.2192403","journal-title":"Expert Rev Neurother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01124-z","article-title":"Neurologic manifestations of the antiphospholipid syndrome - an update","volume":"21","author":"Leal Rato M","year":"2021","unstructured":"Leal Rato M, Bandeira M, Rom\u00e3o VC, Aguiar de Sousa D. Neurologic manifestations of the antiphospholipid syndrome - an update. Curr Neurol Neurosci Rep. 2021, 21:41. 10.1007\/s11910-021-01124-z","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams HP Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993, 24:35-41. 10.1161\/01.str.24.1.35","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo V","year":"2010","unstructured":"Pengo V, Ruffatti A, Legnani C, et al.. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010, 8:237-242. 10.1111\/j.1538-7836.2009.03674.x","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-1304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423424-late-onset-antiphospholipid-syndrome-presenting-with-recurrent-multifocal-ischemic-strokes-diagnostic-and-management-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:07:02Z","timestamp":1785823622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423424-late-onset-antiphospholipid-syndrome-presenting-with-recurrent-multifocal-ischemic-strokes-diagnostic-and-management-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}